High-dose infliximab for treatment of pediatric ulcerative colitis: A survey of clinical practice

doi:10.3748/wjg.v18.i11.1229

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 11

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3261)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-5) series.

Item

Count

PDF

471

HTML

2468

Figures (1-1)

164

Tables (1-5)

158

Sum=3261

Mar 21, 2012 (publication date) through Apr 18, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Mar 21, 2012; 18(11): 1229-1234
Published online Mar 21, 2012. doi: 10.3748/wjg.v18.i11.1229

Full Size Figure Download Figure

Figure 1 Factors that influenced pediatric gastroenterologists to not increase infliximab dosing depicted as a 5-point Likert scale. IFX: Infliximab.

Citation: Nattiv R, Wojcicki JM, Garnett EA, Gupta N, Heyman MB. High-dose infliximab for treatment of pediatric ulcerative colitis: A survey of clinical practice. World J Gastroenterol 2012; 18(11): 1229-1234
URL: https://www.wjgnet.com/1007-9327/full/v18/i11/1229.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i11.1229